[Galectins in squamous cell carcinomas of the head and neck cancers].
Cancers of head and neck represents about 5% of all tumors. 80 to 90% of these tumors are constituted of squamous cell carcinomas. Despite a rapid progress in diagnostics and therapy the overall 5-year survival of this type of cancer is among the lowest of the major cancer types. This unfavourable situation needs the extensive research to found new markers to better characterize biological behavior of tumors as a rational background for more sophisticated therapeutic modalities. Among the most promising markers are endogenous lectins called galectins and their ligands. Especially galectin-1, -3 and -7 play a key role in pathology of squamous cell carcinomas.
Cada
Z
Z
Karlova Univerzita, 1. lékarská fakulta, Anatomický ústav, Praha.
Plzák
J
J
Chovanec
M
M
Dvoránková
B
B
Lacina
L
L
Szabó
P
P
Smetana
K
K
Betka
J
J
D014408:Biomarkers, Tumor / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000737:chemistry / Q000175:diagnosis*; D037161:Galectins / Q000032:analysis*; D006258:Head and Neck Neoplasms / Q000737:chemistry / Q000175:diagnosis*; D006801:Humans
D014408:Biomarkers, Tumor; D037161:Galectins